October 19, 2011 8:30am EDT
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE:OPK) today announced that Claros Diagnostics and
Columbia University have been named as runner-up in the Medical Devices
category of this year’s prestigious Wall Street Journal Technology
Innovation Awards. OPKO recently acquired Claros, a Woburn,
Massachusetts based company that has a developed a novel
microfluidics-based test that, with only a finger stick drop of blood,
provides high performance quantitative test results within minutes from
a small but sophisticated desktop analyzer.
The Wall Street Journal received over 600 applications from companies,
organizations and individuals in 31 countries. Ultimately, judges chose
35 winners and runners-up in 16 categories. There were three primary
criteria on which the judges made their selections. Does the innovation
break with conventional ideas or processes in its field; Does it go
beyond marginal improvements on something that already exists; and, Will
it have a wide impact in its field or on future technology. The winners
include such names as International Business Machines Corp., Novartis
AG, Intel Corp. Abbott Laboratories, Xerox Corp. and runners-up
Hewlett-Packard Co. and Yahoo Inc.
The award recipients will be honored at an awards ceremony and dinner on
November 8 th , 2011 in Redwood City, California, at the
Sofitel San Francisco Bay Hotel.
“OPKO is very proud of Claros and its recognition as a leading
technology innovator by The Wall Street Journal,” said Dr. Phillip
Frost, OPKO’s Chairman and Chief Executive Officer.
This is the latest honor given to Claros. In February 2011, Claros was
named by MIT’s Technology Review as one of the 50 Most Innovative
Companies in the World for 2011.
About OPKO Health, Inc.
OPKO is a multi-national biopharmaceutical and diagnostics company that
seeks to establish industry-leading positions in large and rapidly
growing medical markets by leveraging its discovery, development and
commercialization expertise and novel and proprietary technologies.
This press release contains “forward-looking statements,” as that
term is defined under the Private Securities Litigation Reform Act of
1995 (PSLRA), which statements may be identified by words such as
“expects,” “plans,” “projects,” “will,” “may,” “anticipates,”
“believes,” “should,” “intends,” “estimates,” and other words of similar
meaning, including statements regarding the Claros platform and product
candidates, the ability to provide high performance quantitative test
results within minutes, the utility of the product in various blood
diagnostics markets, as well as other non-historical statements about
our expectations, beliefs or intentions regarding our business,
technologies and products, financial condition, strategies or prospects.
Many factors could cause our actual activities or results to differ
materially from the activities and results anticipated in
forward-looking statements. These factors include those described in our
filings with the Securities and Exchange Commission, as well as
integration issues involving Claros, and risks inherent in funding,
developing and obtaining regulatory approvals of new,
commercially-viable and competitive products and treatments. In
addition, forward-looking statements may also be adversely affected by
general market factors, competitive product development, product
availability, federal and state regulations and legislation, the
regulatory process for new products and indications, manufacturing
issues that may arise, patent positions and litigation, among other
factors. The forward-looking statements contained in this press release
speak only as of the date the statements were made, and we do not
undertake any obligation to update forward-looking statements. We intend
that all forward-looking statements be subject to the safe-harbor
provisions of the PSLRA.
OPKO Health, Inc.
Steven D. Rubin, 305-575-6015
Source: OPKO Health, Inc.
Released October 19, 2011
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page